1. Home
  2. RNW vs IMCR Comparison

RNW vs IMCR Comparison

Compare RNW & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$7.56

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
IMCR
Founded
2011
2008
Country
United Kingdom
United Kingdom
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
1.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RNW
IMCR
Price
$7.56
$36.52
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$7.83
$67.00
AVG Volume (30 Days)
880.7K
338.1K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
413.66
N/A
EPS
0.26
N/A
Revenue
$1,382,164,625.00
$379,590,000.00
Revenue This Year
N/A
$32.31
Revenue Next Year
$17.03
$10.50
P/E Ratio
$28.86
N/A
Revenue Growth
46.76
28.11
52 Week Low
$5.42
$23.15
52 Week High
$8.24
$40.72

Technical Indicators

Market Signals
Indicator
RNW
IMCR
Relative Strength Index (RSI) 51.27 49.05
Support Level $7.55 $35.35
Resistance Level $7.69 $40.71
Average True Range (ATR) 0.08 1.82
MACD 0.01 -0.45
Stochastic Oscillator 43.13 22.55

Price Performance

Historical Comparison
RNW
IMCR

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: